CHINA- DSM-Firmenich has initiated legal action for patent infringement against Shandong Haineng Bioengineering only weeks after taking similar measures against China-based Anhui Shengda Bio-pharm Co and Zhejiang Shengda Bio-pharm – a biotin manufacturer and supplier collectively referred to as Shengda. The recently merged nutrition specialist took action against Shandong Haineng Bioengineering Co. Ltd., alleging that certain Haineng swine compound premix…
Read MoreDSM-Firmenich files petition against 2nd Chinese firm on allegations of unlawfully using its patented technology
